A new study suggests people taking popular injected medications for weight loss, including Wegovy, Ozempic, Saxenda and Victoza, may be at higher risk for serious digestive problems such as stomach paralysis, pancreatitis, and bowel obstructions, compared with those taking other types of weight loss medications
Obesity Research & Clinical Practice
The program included advice from a nutritionist on healthy eating, increasing exercise, and overcoming the psychological barriers to weight loss, access to doctors, nurses, and psychologists through the app, and a course of the weight loss drug semaglutide (Ozempic or Wegovy)
Remove both caps from the syringe and fill the syringe with air by pulling the plunger back to your prescribed dose
Highlights from the July 2024 study include: Our main finding is that prescribed semaglutide is associated with an increased risk of NAION. Patients with diabetes who took semaglutide were more than four times more likely to develop NAION than those on other medications
